209 related articles for article (PubMed ID: 37729281)
1. OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?
Assumpção PP; Silva JMCD; Calcagno DQ; Barra WF; Ishak G; Kassab P
Arq Bras Cir Dig; 2023; 36():e1752. PubMed ID: 37729281
[TBL] [Abstract][Full Text] [Related]
2. Treatment Strategies for Oligometastatic Breast Cancer.
Nesbit EG; Donnelly ED; Strauss JB
Curr Treat Options Oncol; 2021 Aug; 22(10):94. PubMed ID: 34426881
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of oligometastatic disease in gastric cancer.
Jin P; Ji X; Tian Y
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):638-645. PubMed ID: 32147440
[TBL] [Abstract][Full Text] [Related]
4. Pretherapeutic evaluation of patients with upper gastrointestinal tract cancer using endoscopic and laparoscopic ultrasonography.
Mortensen MB
Dan Med J; 2012 Dec; 59(12):B4568. PubMed ID: 23290296
[TBL] [Abstract][Full Text] [Related]
5. Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review.
Corrao G; Zaffaroni M; Bergamaschi L; Augugliaro M; Volpe S; Pepa M; Bonizzi G; Pece S; Amodio N; Mistretta FA; Luzzago S; Musi G; Alessi S; La Fauci FM; Tordonato C; Tosoni D; Cattani F; Gandini S; Petralia G; Pravettoni G; De Cobelli O; Viale G; Orecchia R; Marvaso G; Jereczek-Fossa BA
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34208918
[TBL] [Abstract][Full Text] [Related]
6. [Treatment options for oligometastatic gastric cancer].
Jung MK; Ott K; Chevallay M; Mönig SP
Chirurg; 2021 Jun; 92(6):515-521. PubMed ID: 33544151
[TBL] [Abstract][Full Text] [Related]
7. The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review.
Berzenji L; Debaenst S; Hendriks JMH; Yogeswaran SK; Lauwers P; Van Schil PE
Transl Lung Cancer Res; 2021 Jul; 10(7):3409-3419. PubMed ID: 34430376
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. The society for gastrointestinal intervention. Are we, as an organization of disparate disciplines, cooperative or competitive?
Kozarek RA
Gut Liver; 2010 Sep; 4 Suppl 1(Suppl 1):S1-8. PubMed ID: 21103287
[TBL] [Abstract][Full Text] [Related]
10. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
Kent CL; McDuff SGR; Salama JK
Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
[TBL] [Abstract][Full Text] [Related]
11. Defining oligometastatic non-small cell lung cancer: concept versus biology, a literature review.
Mentink JF; Paats MS; Dumoulin DW; Cornelissen R; Elbers JBW; Maat APWM; von der Thüsen JH; Dingemans AC
Transl Lung Cancer Res; 2021 Jul; 10(7):3329-3338. PubMed ID: 34430370
[TBL] [Abstract][Full Text] [Related]
12. The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited.
Deek MP; Van der Eecken K; Phillips R; Parikh NR; Isaacsson Velho P; Lotan TL; Kishan AU; Maurer T; ; Boutros PC; Hovens C; Abramowtiz M; Pollack A; Desai N; Stish B; Feng FY; Eisenberger M; Carducci M; Pienta KJ; Markowski M; Paller CJ; Antonarakis ES; Berlin A; Ost P; Tran PT
Eur Urol; 2021 Nov; 80(5):632-640. PubMed ID: 33419682
[TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
14. The current role of precision surgery in oligometastatic prostate cancer.
von Deimling M; Rajwa P; Tilki D; Heidenreich A; Pallauf M; Bianchi A; Yanagisawa T; Kawada T; Karakiewicz PI; Gontero P; Pradere B; Ploussard G; Rink M; Shariat SF
ESMO Open; 2022 Dec; 7(6):100597. PubMed ID: 36208497
[TBL] [Abstract][Full Text] [Related]
15. Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.
Kroese TE; van Hillegersberg R; Schoppmann S; Deseyne PRAJ; Nafteux P; Obermannova R; Nordsmark M; Pfeiffer P; Hawkins MA; Smyth E; Markar S; Hanna GB; Cheong E; Chaudry A; Elme A; Adenis A; Piessen G; Gani C; Bruns CJ; Moehler M; Liakakos T; Reynolds J; Morganti A; Rosati R; Castoro C; D'Ugo D; Roviello F; Bencivenga M; de Manzoni G; Jeene P; van Sandick JW; Muijs C; Slingerland M; Nieuwenhuijzen G; Wijnhoven B; Beerepoot LV; Kolodziejczyk P; Polkowski WP; Alsina M; Pera M; Kanonnikoff TF; Nilsson M; Guckenberger M; Monig S; Wagner D; Wyrwicz L; Berbee M; Gockel I; Lordick F; Griffiths EA; Verheij M; van Rossum PSN; van Laarhoven HWM;
Eur J Cancer; 2022 Mar; 164():18-29. PubMed ID: 35134666
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management.
Correa RJ; Salama JK; Milano MT; Palma DA
Cancer J; 2016; 22(4):247-56. PubMed ID: 27441744
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Oligometastatic GI Cancers.
Marcinak CT; Schwartz PB; Basree MM; Hurst N; Bassetti M; Kratz JD; Uboha NV
Am Soc Clin Oncol Educ Book; 2024 Jan; 44():e430152. PubMed ID: 38190577
[TBL] [Abstract][Full Text] [Related]
18. Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional Study.
Christ SM; Pohl K; Muehlematter UJ; Heesen P; Kühnis A; Willmann J; Ahmadsei M; Badra EV; Kroeze SGC; Mayinger M; Andratschke N; Huellner M; Guckenberger M
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):596-602. PubMed ID: 35908582
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Tumor Board Recommendations for Oligometastatic Malignancies: A Prospective Single-Center Analysis.
Galata C; Wimmer E; Kasper B; Wenz F; Reißfelder C; Jakob J
Oncol Res Treat; 2019; 42(3):87-94. PubMed ID: 30814474
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
